Erratum: Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1 (Biochemistry (2012) 51:1 (194-204) DOI: 10.1021/bi201259y);Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1

Biochemistry

Volumn 51, Issue 1, 2012, Pages 194-204

  Beste, Kerstin Y ^a   Burhenne, Heike ^a   Kaever, Volkhard ^a   Stasch, Johannes Peter ^b   Seifert, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC COMPOUNDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDES; SUBSTRATES;

CYCLIC NUCLEOTIDE; FUNCTIONAL PROPERTIES; GUANYLYL CYCLASE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRIES; PHYSIOLOGICAL PROCESS; PYRIMIDINE NUCLEOSIDES; SOLUBLE GUANYLYL CYCLASE (SGC); SUBSTRATE SPECIFICITY;

SIGNAL TRANSDUCTION;

GUANYLATE CYCLASE; MAGNESIUM ION; MANGANESE; RECOMBINANT ENZYME;

ARTICLE; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 84856847677     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi3002715     Document Type: Erratum

References (69)

1. Kots, A. Y., Martin, E., Sharina, I. G., and Murad, F. (2009) A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Handb. Exp. Pharmacol., 191, 1-14.
2. Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K. P., and Waldman, S. A. (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52, 375-414.
3. Hoffmann, L. S., Schmidt, P. M., Keim, Y., Schaefer, S., Schmidt, H. H. H. W., and Stasch, J. P. (2009) Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation. Br. J. Pharmacol. 157, 781-795.
4. Derbyshire, E. R., and Marletta, M. A. (2009) Biochemistry of soluble guanylate cyclase. Handb. Exp. Pharmacol. 191, 17-31.
5. Russwurm, M., Behrends, S., Harteneck, C., and Koesling, D. (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 335, 125-130. (Pubitemid 28477058)
6. Stasch, J.-P., Pacher, P., and Evgenov, O. V. (2011) Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 123, 2263-2273.
7. Garthwaite, J., Southam, E., Boulton, C. L., Nielsen, E. B., Schmidt, K., and Mayer, B. (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48, 184-188.
8. Zhao, Y., Brandish, P. E., DiValentin, M., Schelvis, J. P. M., Babcock, G. T., and Marletta, M. A. (2000) Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 39, 10848-10854.
9. Gille, A., Lushington, G. H., Mou, T.-C., Doughty, M. B., Johnson, R. A., and Seifert, R. (2004) Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides. J. Biol. Chem. 279, 19955-19969. (Pubitemid 38623438)
10. Suryanarayana, S., Go, M., Hu, M., Gille, A., Mou, T.-C., Sprang, S. R., Richter, M., and Seifert, R. (2009) Differential inhibition of various adenylyl cyclase isoforms and substituted nucleoside 5'-triphosphates. J. Pharmacol. Exp. Ther. 330, 687-695.
11. Pinto, C., Lushington, G. H., Richter, M., Gille, A., Geduhn, J., König, B., Mou, T.-C., Sprang, S. R., and Seifert, R. (2011) Structureactivity relationships for the interactions of 2'-and 3'-(O)-(Nmethyl) anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases. Biochem. Pharmacol. 82, 358-370.
12. Hardman, J. G., and Sutherland, E. W. (1969) Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3',5'-monophosphate from guanosine triphosphate. J. Biol. Chem. 244, 6363-6370.
13. Zwiller, J., Basset, P., and Mandel, P. (1981) Rat brain guanylate cyclase. Purification, amphiphilic properties and immunological characterization. Biochim. Biophys. Acta 658, 64-75. (Pubitemid 11145387)
14. Mittal, C. K., Braughler, J. M., Ichihara, K., and Murad, F. (1979) Synthesis of adenosine 3',5'-monophosphate by guanylate cyclase, a new pathway for its formation. Biochim. Biophys. Acta 585, 333-342. (Pubitemid 9209697)
15. Derbyshire, E. R., Fernhoff, N. B., Deng, S., and Marletta, M. A. (2009) Nucleotide regulation of soluble guanylate cyclase substrate specificity. Biochemistry 48, 7519-7524.
16. Garbers, D. L., Suddath, J. L., and Hardman, J. G. (1975) Enzymatic formation of inosine 3',5'-monophosphate and of 2'-deoxyguanosine 3',5'-monophosphate. Inosinate and deoxyguanylate cyclase activity. Biochim. Biophys. Acta 377, 174-185.
17. Gerzer, R., Böhme, E., Hofmann, F., and Schultz, G. (1981) Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett. 132, 71-74.
18. Gerzer, R., Hofmann, F., Böhme, E., Ivanova, K., Spies, C., and Schultz, G. (1981) Purification of soluble guanylate cyclase without loss of stimulation by sodium nitroprusside. Adv. Cyclic Nucleotide Res. 14, 255-261.
19. Gerzer, R., Hofmann, F., and Schultz, G. (1981) Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur. J. Biochem. 116, 479-486. (Pubitemid 11055723)
20. Waldman, S. A., Rapoport, R. M., and Murad, F. (1984) Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J. Biol. Chem. 259, 14332-14334. (Pubitemid 15222241)
21. Horton, J. K., Martin, R. C., Kalinka, S., Cushing, A., Kitcher, J. P., O'Sullivan, M. J., and Baxendale, P. M. (1992) Enzyme immunoassays for the estimation of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological fluids. J. Immunol. Methods 155, 31-40.
22. Werner, K., Schwede, F., Genieser, H.-G., Geiger, J., and Butt, E. (2011) Quantification of cAMP and cGMP analogs in intact cells: Pitfalls in enzyme immunoassays for cyclic nucleotides. Naunyn-Schmiedeberg's Arch. Pharmacol. 384, 169-176.
23. Hoenicka, M., Becker, E. M., Apeler, H., Sirichoke, T., Schröder, H., Gerzer, R., and Stasch, J. P. (1999) Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: Stimulation by YC-1, nitric oxide, and carbon monoxide. J. Mol. Med. 77, 14-23. (Pubitemid 29146177)
24. Göttle, M., Dove, S., Kees, F., Schlossmann, J., Geduhn, J., König, B., Shen, Y., Tang, W.-J., Kaever, V., and Seifert, R. (2010) Cytidylyl and uridylyl cyclase activity of Bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry 49, 5494-5503.
25. Ruiz-Stewart, I., Tiyyagura, S. R., Lin, J. E., Kazerounian, S., Pitari, G. M., Schulz, S., Martin, E., Murad, F., and Waldman, S. A. (2004) Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc. Natl. Acad. Sci. U.S.A. 101, 37-42. (Pubitemid 38084199)
26. Rauch, A., Leipelt, M., Russwurm, M., and Steegborn, C. (2008) Crystal structure of the guanylyl cyclase Cya2. Proc. Natl. Acad. Sci. U.S.A. 105, 15720-15725.
27. Winger, J. A., Derbyshire, E. R., Lamers, M. H., Marletta, M. A., and Kuriyan, J. (2008) The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase. BMC Struct. Biol. 8, 42.
28. Tesmer, J. J., Sunahara, R. K., Johnson, R. A., Gosselin, G., Gilman, A. G., and Sprang, S. R. (1999) Two-metal-ion catalysis in adenylyl cyclase. Science 285, 756-760.
29. Chang, F.-J., Lemme, S., Sun, Q., Sunahara, R. K., and Beuve, A. (2005) Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase. J. Biol. Chem. 280, 11513-11519. (Pubitemid 40418462)
30. Emmons, T. L., Mathis, K. J., Shuck, M. E., Reitz, B. A., Curran, D. F., Walker, M. C., Leone, J. W., Day, J. E., Bienkowski, M. J., Fischer, H. D., and Tomasselli, A. G. (2009) Purification and characterization of recombinant human soluble guanylate cyclase produced from baculovirus-infected insect cells. Protein Expression Purif. 65, 133-139.
31. Schmidt, P., Schramm, M., Schröder, H., and Stasch, J.-P. (2003) Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur. J. Pharmacol. 468, 167-174. (Pubitemid 36712896)
32. Mathis, K. J., Emmons, T. L., Curran, D. F., Day, J. E., and Tomasselli, A. G. (2008) High yield purification of soluble guanylate cyclase from bovine lung. Protein Expression Purif. 60, 58-63.
33. Tomita, T., Tsuyama, S., Imai, Y., and Kitagawa, T. (1997) Purification of bovine soluble guanylate cyclase and ADP-ribosylation on its small subunit by bacterial toxins. J. Biochem. 122, 531-536. (Pubitemid 27443228)
34. Stone, J. R., and Marletta, M. A. (1995) Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry 34, 14668-14674.
35. Humbert, P., Niroomand, F., Fischer, G., Mayer, B., Koesling, D., Hinsch, K. D., Gausepohl, H., Frank, R., Schultz, G., and Böhme, E. (1990) Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur. J. Biochem. 190, 273-278. (Pubitemid 20201512)
36. Ohlstein, E. H., Wood, K. S., and Ignarro, L. J. (1982) Purification and properties of heme-deficient hepatic soluble guanylate cyclase: Effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX. Arch. Biochem. Biophys. 218, 187-198.
37. Ignarro, L. J., Degnan, J. N., Baricos, W. H., Kadowitz, P. J., and Wolin, M. S. (1982) Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, hemereconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta 718, 49-59.
38. Yazawa, S., Tsuchiya, H., Hori, H., and Makino, R. (2006) Functional characterization of two nucleotide-binding sites in soluble guanylate cyclase. J. Biol. Chem. 281, 21763-21770. (Pubitemid 44181880)
39. Cech, S. Y., and Ignarro, L. J. (1977) Cytidine 3',5'-monophosphate (cyclic CMP) formation in mammalian tissues. Science 198, 1063-1065. (Pubitemid 8239007)
40. Gaion, R. M., and Krishna, G. (1979) Cytidylate cyclase: The product isolated by the method of Cech and Ignarro is not cytidine 3',5'-monophosphate. Biochem. Biophys. Res. Commun. 86, 105-111.
41. Anderson, T. R. (1982) Cyclic cytidine 3',5'-monophosphate (cCMP) in cell regulation. Mol. Cell. Endocrinol. 28, 373-385. (Pubitemid 13253568)
42. Yamamoto, I., Takai, T., and Mori, S. (1989) Cytidylate cyclase activity in mouse tissues: The enzymatic conversion of cytidine 5'-triphosphate to cytidine 3',5'-cyclic monophosphate (cyclic CMP). Biochim. Biophys. Acta 993, 191-198. (Pubitemid 20004636)
43. Newton, R. P., Salvage, B. J., and Hakeem, N. A. (1990) Cytidylate cyclase: Development of assay and determination of kinetic properties of a cytidine 3',5'-cyclic monophosphate-synthesizing enzyme. Biochem. J. 265, 581-586. (Pubitemid 20042006)
44. Muto, N., Kanoh, M., and Yamamoto, I. (1993) Cytidylate cyclase activity is stimulated via activation of a guanine nucleotidebinding protein. Life Sci. 52, 13-20. (Pubitemid 223039978)
45. Rothkegel, C., Schmidt, P. M., Atkins, D.-J., Hoffmann, L. S., Schmidt, H. H. H. W., Schröder, H., and Stasch, J.-P. (2007) Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo. Mol. Pharmacol. 72, 1181-1190. (Pubitemid 350012592)
46. Newton, R. P., Salih, S. G., Salvage, B. J., and Kingston, E. E. (1984) Extraction, purification and identification of cytidine 3',5'-cyclic monophosphate from rat tissues. Biochem. J. 221, 665-673. (Pubitemid 14061648)
47. Newton, R. P., Kingston, E. E., Hakeem, N. A., Salih, S. G., Beynon, J. H., and Moyse, C. D. (1986) Extraction, purification, identification and metabolism of 3',5'-cyclic UMP, 3',5'-cyclic IMP and 3',5'-cyclic dTMP from rat tissues. Biochem. J. 236, 431-439. (Pubitemid 16036989)
48. Ervens, J., and Seifert, R. (1991) Differential modulation by N4,2'-O-dibutyryl cytidine 3':5'-cyclic monophosphate of neutrophil activation. Biochem. Biophys. Res. Commun. 174, 258-267.
49. Desch, M., Schinner, E., Kees, F., Hofmann, F., Seifert, R., and Schlossmann, J. (2010) Cyclic cytidine 3',5'-monophosphate (cCMP) signals via cGMP kinase I. FEBS Lett. 584, 3979-3984.
50. Reinecke, D., Burhenne, H., Sandner, P., Kaever, V., and Seifert, R. (2011) Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated. FEBS Lett. 585, 3259-3262.
51. Wolter, S., Golombek, M., and Seifert, R. (2011) Differential activation of cAMP-and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides. Biochem. Biophys. Res. Commun., 415, 563-566.
52. Vila-Petroff, M. G., Younes, A., Egan, J., Lakatta, E. G., and Sollott, S. J. (1999) Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ. Res. 84, 1020-1031. (Pubitemid 29227681)
53. Wörner, R., Lukowski, R., Hofmann, F., and Wegener, J. W. (2007) cGMP signals mainly through cAMP kinase in permeabilized murine aorta. Am. J. Physiol. 292, H237-H244. (Pubitemid 46105184)
54. Ciani, E., Guidi, S., Della Valle, G., Perini, G., Bartesaghi, R., and Contestabile, A. (2002) Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation. J. Biol. Chem. 277, 49896-49902. (Pubitemid 36014438)
55. Xu, H.-L., Wolde, H. M., Gavrilyuk, V., Baughman, V. L., and Pelligrino, D. A. (2004) cAMP modulates cGMP-mediated cerebral arteriolar relaxation in vivo. Am. J. Physiol. 287, H2501-H2509. (Pubitemid 39557118)
56. Voth, D. E., Hamm, E. E., Nguyen, L. G., Tucker, A. E., Salles, I. I., Ortiz-Leduc, W., and Ballard, J. D. (2005) Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell. Microbiol. 7, 1139-1149. (Pubitemid 41030939)
57. Jitrapakdee, S., St Maurice, M., Rayment, I., Cleland, W. W., Wallace, J. C., and Attwood, P. V. (2008) Structure, mechanism and regulation of pyruvate carboxylase. Biochem. J. 413, 369-387.
58. Kim, K. H., Rodriguez, A. M., Carrico, P. M., and Melendez, J. A. (2001) Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase. Antioxid. Redox Signaling 3, 361-373. (Pubitemid 32646028)
59. Barceloux, D. G. (1999) Manganese. J. Toxicol. Clin. Toxicol. 37, 293-307. (Pubitemid 29292913)
60. Rucker, D., Thadhani, R., and Tonelli, M. (2010) Trace element status in hemodialysis patients. Semin. Dial. 23, 389-395.
61. Wood, R. J. (2009) Manganese and birth outcome. Nutr. Rev. 67, 416-420.
62. Bidmon, H.-J., Mohlberg, H., Habermann, G., Buse, E., Zilles, K., and Behrends, S. (2006) Cerebellar localization of the NOreceptive soluble guanylyl cyclase subunits-a2/ß1 in non-human primates. Cell Tissue Res. 326, 707-714. (Pubitemid 44786370)
63. Tresguerres, M., Levin, L. R., and Buck, J. (2011) Intracellular cAMP signaling by soluble adenylyl cyclase. Kidney Int. 79, 1277-1288.
64. Fischmeister, R., Castro, L. R. V., Abi-Gerges, A., Rochais, F., Jurevicius, J., Leroy, J., and Vandecasteele, G. (2006) Compartmentation of cyclic nucleotide signaling in the heart: The role of cyclic nucleotide phosphodiesterases. Circ. Res. 99, 816-828. (Pubitemid 44556380)
65. Erdorf, M., Mou, T.-C., and Seifert, R. (2011) Impact of divalent metal ions on regulation of adenylyl cyclase isoforms by forskolin analogs. Biochem. Pharmacol. 82, 1673-1681.
66. Joubert, S., McNicoll, N., and De Léan, A. (2007) Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A. Biochem. Pharmacol. 73, 954-963. (Pubitemid 46283581)
67. Mou, T.-C., Gille, A., Suryanarayana, S., Richter, M., Seifert, R., and Sprang, S. R. (2006) Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine and pyrimidine nucleotide inhibitors. Mol. Pharmacol. 70, 878-886. (Pubitemid 44268445)
68. Mou, T.-C., Gille, A., Fancy, D. A., Seifert, R., and Sprang, S. R. (2005) Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2'(3')-O-(N-methylanthraniloyl)-guanosine 5'-triphosphate. J. Biol. Chem. 280, 7253-7261. (Pubitemid 40341283)
69. Hübner, M., Dixit, A., Mou, T.-C., Lushington, G. H., Pinto, C., Gille, A., Geduhn, J., König, B., Sprang, S. R., and Seifert, R. (2011) Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-O-(N-methylanthraniloyl)-inosine 5'-triphosphate. Mol. Pharmacol. 80, 87-96.